After curative resection, the prognosis of gastroesophageal adenocarcinoma is poor. This phase III trial was designed to evaluate the benefit in overall survival (OS) of perioperative fluorouracil ...
The perioperative timeframe—days before and after tumour excision—is pivotal in determining long-term cancer outcomes, disproportionally to its short duration Potential metastasis-promoting aspects of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback